Dian Diagnostics: Q3 net profit attributable to parent company 250 million yuan, up 438.03% year-on-year

Dian Diagnostics announced on October 19 that in the third quarter of 2026, it achieved operating revenue of 2.635 billion yuan, a year-on-year increase of 0.23%; net profit attributable to shareholders of the parent company was 250 million yuan, a year-on-year increase of 438.03%; basic earnings per share were 0.4088 yuan. In the first three quarters, it achieved operating revenue of 7.409 billion yuan, a year-on-year decrease of 2.07%; net profit attributable to shareholders of the parent company was 482 million yuan, a year-on-year increase of 750.28%; basic earnings per share were 0.789 yuan. During the reporting period, the company's operating revenue improved quarter by quarter, and the trend of operational recovery steadily emerged; it deepened its strategic business layout and continued to increase the revenue share of high-value businesses; it continued to expand high-value customers, further increasing its market share; it comprehensively deepened refined management, driving the overall gross margin up 1.35 percentage points year on year, and the profit structure and profit quality continued to be consolidated.